These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 538291)

  • 1. [Remission of the nephrotic syndrome with minimal changes by spironolactone].
    Marco Franco JE; Alarcón Zurita A; Piza Buñola C; Morey Molina A; Ballesteros Fernández A
    Rev Clin Esp; 1979 Oct; 155(1):63-5. PubMed ID: 538291
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prednisone and immunosuppressive agents in the therapy of nephrotic syndrome in infancy].
    Gabriele C; Gabriele S; Bandiermonte Z
    Minerva Pediatr; 1971 Apr; 23(16):725-32. PubMed ID: 5555704
    [No Abstract]   [Full Text] [Related]  

  • 3. [Amyloidosis in childhood].
    Steinitz L; Schreiter G
    Padiatr Grenzgeb; 1971; 10(4):261-8. PubMed ID: 5147655
    [No Abstract]   [Full Text] [Related]  

  • 4. [Controlled clinical study on 2 antialdosterone diuretics in the nephrotic syndrome].
    Russo R; Schena FP; Colombo Pirola L
    Clin Ter; 1984 Apr; 109(1):23-9. PubMed ID: 6233076
    [No Abstract]   [Full Text] [Related]  

  • 5. [Considerations on therapy of genuine nephrotic syndrome in childhood].
    Fornara P
    Minerva Med; 1968 Dec; 59(97):5251-66. PubMed ID: 5715832
    [No Abstract]   [Full Text] [Related]  

  • 6. The nephrotic syndrome in an elderly woman. An unusual association with an unusual response to therapy.
    Schneider PJ; Eytel CS
    Geriatrics; 1969 Jun; 24(6):147-52. PubMed ID: 5789855
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ifosfamide in the treatment of nephrotic syndrome (author's transl)].
    Gekle D; Daigeler C
    Klin Padiatr; 1977 Sep; 189(5):370-5. PubMed ID: 562447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial remission-inducing effect of very low-dose cyclosporin monotherapy for minimal-change nephrotic syndrome in Japanese adults.
    Matsumoto H; Nakao T; Okada T; Nagaoka Y; Shino T; Yoshino M; Hidaka H
    Clin Nephrol; 2001 Feb; 55(2):143-8. PubMed ID: 11269678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine utilization in idiopathic nephrotic syndrome in children.
    Saeed B; Ossman MI; Sheriff S
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):497-502. PubMed ID: 17186683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cyclosporin A versus cyclophosphamide in the treatment of nephrotic syndrome in children].
    Podracká L; Böör A; Sasinka M
    Cas Lek Cesk; 2008; 147(1):38-43. PubMed ID: 18323041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the clinical and metabolic effects of an inhibitor of kaliuresis, amipromyzide (MK 870)].
    Guedon M; Cote M; Gay M
    J Urol Nephrol (Paris); 1968; 74(4):363-9. PubMed ID: 5675118
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nephrotic syndrome. Treatment and control with serial renal biopsy].
    Zegarra Puppi J; Rivera Felices J; Larrea Ramírez P; Olivo R
    An Fac Med Lima; 1966 Sep; 49(3):355-68. PubMed ID: 5995784
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune status of children suffering from minimal change nephrotic syndrome.
    Saxena S; Andal A; Sharma S; Chandra M; Saxena RK; Saxena HM
    Indian J Pathol Microbiol; 1992 Jul; 35(3):171-9. PubMed ID: 1344152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nephrotic syndrome.
    Milford DV
    Br J Hosp Med; 1995 Feb 15-28; 53(4):147-51. PubMed ID: 7735663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipoid nephrosis in a child with advanced Hodgkin's lymphoma].
    Gordillo Paniagua G; Velázquez Jones L; Scovino Gudiño R; Arroyo Sierra J; Silva Sosa M; Mota Hernández F
    Bol Med Hosp Infant Mex; 1977; 34(4):815-21. PubMed ID: 911442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The patient with over 100 relapses of minimal change nephrotic syndrome: prolonged complete remission after chlorambucil treatment.
    Carreño A; Morales E; Domínguez-Gil B; Herrero JC; Ortiz M; González E; Praga M
    Nephrol Dial Transplant; 2000 Jun; 15(6):922-3. PubMed ID: 10831662
    [No Abstract]   [Full Text] [Related]  

  • 17. Stability of remission in minimal lesion nephrotic syndrome after treatment with prednisolone and cyclophosphamide.
    Dundon S; O'Callaghan U; Raftery J
    Int J Pediatr Nephrol; 1980 Mar; 1(1):22-5. PubMed ID: 7343524
    [No Abstract]   [Full Text] [Related]  

  • 18. [Steroid spirolactones--antagonists of mineralocorticoids].
    Linèt O
    Cesk Farm; 1969 Jun; 18(4):218-26. PubMed ID: 4895579
    [No Abstract]   [Full Text] [Related]  

  • 19. [Good results of cyclophosphamide in steroid toxicity in the treatment of nephrotic syndrome caused by minimal-lesion glomerulopathy in childhood].
    de Moor R; de Jong M; Monnens L
    Ned Tijdschr Geneeskd; 1992 May; 136(18):876-80. PubMed ID: 1589052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
    Kyrieleis HA; Levtchenko EN; Wetzels JF
    Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.